Xue Kewei, Li Guixin, Li Xinxin, Guo Yingxue, Li Ao, Wang Wenhao. Effect of umbilical cord blood dendritic cells induced by gastric cancer antigen combined with CIK cells in gastric cancer cell lines SGC-7901[J]. Journal of International Oncology, 2015, 42(7): 485-487.
[1] Sastre J, GarciaSaenz JA, DiazRubio E. Chemotherapy for gastric cancer[J]. World J Gastroenterol, 2006, 12(2): 2004-2013.
[2] Lion E, Smits EL, Berneman ZN. NK cells: key to success of DCbased cancer vaccines[J]. Oncologist, 2012, 17(10): 1256-1270.
[3] Mann DL, Celluzzi CM, Hankey KG, et al. Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers[J]. Ann N Y Acad Sci, 2009, 1174(1): 41-50.
[4] Gao D, Xie X, Zhao P, et al. Autologous tumor lysate pulsed dendritic cell immunotherapy with cytokineinduced killer cells improves survival in gastric and colorectal cancer patients[J]. PLoS One, 2014, 9(4): 93886.
[5] Zhang K, Gao PF, Yu PW, et al. Study on biological characters of SGC7901 gastric cancer celldendritic cell fusion vaccines[J]. World J Gastroenterol, 2006, 12(21): 3438-3441.
[6] Linn YC, Hui KM. Cytokineinduced NKlike T cells: from bench to bedside[J]. Biomed Biotechnol, 2010, 20(10): 43-54.
[7] Ishigami S, Arigami T, Uchikado Y, et al. IL32 expression is an independent prognostic marker for gastric cancer[J].Med Oncol, 2013, 30(2): 472-480.
[8] Lissoni P, Brivio F, Ferrante R, et al. Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer[J]. Int J Biol Markers, 2000, 15(1): 22-25.